Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD — Stella

Home/Acute on Chronic Systolic Congestive Heart Failure/

View on ClinicalTrials.gov

Recruiting

Back to Acute on Chronic Systolic Congestive Heart Failure trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Michigan, Ann Arbor, Michigan

Key details

Sponsor

SeaStar Medical

Collaborators

National Heart, Lung, and Blood Institute (NHLBI), University of Michigan

Enrollment target

~20 participants

Started

October 2025

Primary completion

February 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.